Fundamentals data is not available for this company.
No recent information was found.
Patents Ending, Eli Lilly Chases New Drugs | 01-Oct-2010 | New York Times |
Lilly aborts inhaled insulin plans | 08-Mar-2008 | LA Times |
Lilly Ends Effort to Develop an Inhaled Insulin ... | 08-Mar-2008 | New York Times |
Currency | US Dollars |
Share Price | $ 31.38 |
Change Today | $ -0.13 |
% Change | -0.41 % |
52 Week High | $36.00 |
52 Week Low | $25.70 |
Volume | 5 |
Shares Issued | 156.88m |
Market Cap | $4,922.97m |
RiskGrade | 248 |
You are here: research